Wells Fargo’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.6K Sell
4,006
-1,586
-28% -$10.7K ﹤0.01% 5859
2026
Q1
$36.2K Buy
5,592
+600
+12% +$4.14K ﹤0.01% 5561
2025
Q4
$39.3K Buy
4,992
+208
+4% +$1.34K ﹤0.01% 5629
2025
Q3
$23.4K Hold
4,784
﹤0.01% 5760
2025
Q2
$28.2K Hold
4,784
﹤0.01% 5687
2025
Q1
$27.8K Hold
4,784
﹤0.01% 5599
2024
Q4
$35.9K Hold
4,784
﹤0.01% 5590
2024
Q3
$38.1K Hold
4,784
﹤0.01% 5444
2024
Q2
$40.1K Hold
4,784
﹤0.01% 5373
2024
Q1
$40.8K Buy
4,784
+1,413
+42% +$11.8K ﹤0.01% 5337
2023
Q4
$28.6K Buy
3,371
+612
+22% +$5.81K ﹤0.01% 5502
2023
Q3
$28.1K Hold
2,759
﹤0.01% 5461
2023
Q2
$35.9K Buy
2,759
+1,586
+135% +$19.7K ﹤0.01% 5558
2023
Q1
$10.9K Buy
1,173
+173
+17% +$2K ﹤0.01% 5839
2022
Q4
$10.9K Hold
1,000
﹤0.01% 5517
2022
Q3
$4K Hold
1,000
﹤0.01% 5986
2022
Q2
$7K Hold
1,000
﹤0.01% 5901
2022
Q1
$9K Hold
1,000
﹤0.01% 6313
2021
Q4
$11K Hold
1,000
﹤0.01% 6505
2021
Q3
$15K Buy
+1,000
New +$15.2K ﹤0.01% 6071
2020
Q3
Sell
-300
Closed -$5K 6754
2020
Q2
$5K Hold
300
﹤0.01% 5981
2020
Q1
$3K Buy
+300
New +$3.89K ﹤0.01% 5949

Other funds holding PROF

Wells Fargo's PROF Position: Q2 2026 in Review

Wells Fargo reduced its Profound Medical (PROF) stake by 28% in Q2 2026, selling an estimated $10.7K and leaving 4,006 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5859.

Wells Fargo first reported a position in PROF in Q1 2020 and has held it in 22 quarters since. The position peaked at $40.8K in Q1 2024. 55 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Wells Fargo held 4,006 shares of Profound Medical worth $26.6K as of Q2 2026.
  • Wells Fargo sold 1,586 Profound Medical shares in Q2 2026, an estimated $10.7K.
  • Profound Medical made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5859 holding.
  • Wells Fargo first reported a position in Profound Medical in Q1 2020 and has held it in 22 quarters since.
  • Wells Fargo's Profound Medical position peaked at $40.8K in Q1 2024.
  • 55 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.